Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.

Non-Profit Trusted Source of Non-Commercial Health Information

Protagonist Therape...
 
Notifications
Clear all

Protagonist Therapeutics to Present Phase 3 VERIFY and Long-Term Rusfertide Data at the ...

1 Posts
1 Users
0 Reactions
20 Views
(@Dr. Sokolov)
Joined: 2 weeks ago
Posts: 2
Topic starter  

The Company's proprietary peptide technology platform enables de novo discovery of peptide therapeutics. Two novel peptides derived from ...

https://www.newswire.com/news/protagonist-therapeutics-to-present-phase-3-verify-and-long-term-rusfertide



   
Quote

Leave a reply

Author Name

Author Email

Title *

Maximum allowed file size is 50MB

 
Preview 0 Revisions Saved